The University of Chicago Header Logo

Connection

Clarissa Parker to Cetuximab

Back to Details
This is a "connection" page, showing publications Clarissa Parker has written about Cetuximab.
Clarissa Parker
Connection Strength
0.044
Cetuximab
  1. A multicenter phase II trial of carboplatin and cetuximab for treatment of advanced nonsmall cell lung cancer. Cancer Invest. 2010 Feb; 28(2):208-15.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.